Skip to main content

Bioresorbable Polymers Market worth USD 3.15 billion by 2028, registering a CAGR of 14.1% – Report by Market Research Future (MRFR)

New York, Sept. 15, 2021 (GLOBE NEWSWIRE) — Bioresorbable (Resorbable) Polymers Market Overview: According to a comprehensive research report by Market Research Future (MRFR), Bioresorbable Polymers Market Research Report: Information by Type (Agro-Polymers [Proteins and Polysaccharides] and Bio-polyesters [Polyglycolic Acid, Polylactic Acid, Polycaprolactone, Polydioxanone, and others]), Application (Orthopedics, Drug Delivery, and Others) and Region (Asia-Pacific, North America, Europe, Latin America, and Middle East & Africa) – Forecast till 2028” the market is projected to be worth USD 3.15 billion by 2028, registering a CAGR of 14.1% during the forecast period (2021 – 2028), The market was valued at USD 1.43 billion in 2021.

Market Competitive Analysis:

List of the prominent leaders in the bioresorbable polymers market profiled are:

  • Putnam Plastics (US)
  • Groupe PCAS (France)
  • KLS Martin (US)
  • Koninklijke DSM N.V (The Netherlands)
  • DURECT CORPORATION (US)
  • Merck KGaA (Germany)
  • Poly-Med Inc. (US)
  • Foster Corporation.(US)
  • REVA Medical, Inc.(US).
  • Evonik Industries AG (Germany)
  • Ashland (US)
  • Corbion NV (The Netherlands)


Get Free Sample PDF Brochure

https://www.marketresearchfuture.com/sample_request/969


Market Scope:

Bioresorbable polymers can easily dissolve in body fluids without causing any residual side effects, and the removal of these polymers is done with the help of processes like excretion, assimilation or dissolution via metabolic pathways. Bioresorbable polymers are commonly used in biomedical applications because of their high performance and biocompatibility.

Bioresorbable polymers avoid post-healing surgical interventions for device removal and eliminate the post-surgery risk to the patients. The factor is likely to propel the growth of the global market in the biomedical sector. Owing to their material composition, bioresorbable polymers are widely used in orthopedic devices. The increased use of bioresorbable polymers in capsules in drug delivery applications is fueling the market demand globally.

Market USP Covered

Market Drivers

The major aspect of the growth of bioresorbable polymers is the rise in patient comfort. After surgery, traditional materials left in the body needed another small surgery to take materials out, which might cause risk to the patient. Bioresorbable polymers remove both of these factors because of their property of disintegrating into the body over the years.

The rising demand for bioresorbable polymers for drug delivery is causing bioresorbable polymers’ market growth. The rising adoption of drug delivery is anticipated to be a crucial parameter driving market growth. Furthermore, the integration of 3D printing is anticipated to be a crucial parameter propelling the growth of the bioresorbable polymers market in the forecasted era. The minute differentiations needed in bioresorbable polymers as per the constitution of several patients and the different situations in every case can be integrated much more reliably and efficiently with 3D printing.


Browse In-depth Market Research Report (185 pages) on Bioresorbable Polymers Industry

https://www.marketresearchfuture.com/reports/bioresorbable-polymers-market-969


Market Restraints

However, because of the technological sophistication of bioresorbable polymers, the prices are a little more than traditional medical polymers. It is considered being a vital parameter hampering the market expansion in developing regions. The lack of advanced healthcare infrastructure in emerging economies is also likely to impede the bioresorbable polymers market.

COVID-19 Analysis

The emergence of COVID-19 is having a significant impact on economic growth globally. The pandemic is impacting several industries like oil and gas, aerospace, construction, automotive, etc. As bioresorbable polymers have a broad range of applications in all of these industry sectors, the declining operations of these end-use sectors are having a direct impact over the bioresorbable polymers market.

Segment Overview

The Global Bioresorbable Polymers Market has been classified into various segments based on type, end-use, and region. The market is classified into proteins, polysaccharides, polycaprolactone, polyglycolic acid, polylactic acid, and others based on product type. Polylactic acid (PLA)  based bioresorbable polymers segment has recorded a maximum market share of 29% in 2015. The safety mainly attributes it offers while getting removed by the body’s excretory system and its ability to get naturally converted into lactic acid in the body at low temperatures.

Based on application, the classification is done into orthopedics, drug delivery, and others. Among these, the orthopedics segment held the top position in the global market with the largest market due to high demand in the knee and trauma sub-applications.


Share your Queries
https://www.marketresearchfuture.com/enquiry/969


Regional Analysis

The Global Bioresorbable Polymers Market is divided into regions like the Middle East & Africa, Latin America, North America, Asia-Pacific and Europe. The North American region holds the top position in the global market with maximum share in 2018. This is mainly driven by the growing demand for Bioresorbable polymers in developed biomedical industries in the North American region.

Asia-Pacific recorded a significant market share in 2018 and is anticipated to grow at maximum CAGR throughout the forecast period. The rising demand for bioresorbable polymers in growing healthcare industries in emerging economies allied with increasing consumer awareness in the region is likely to boost demand for the market in these regions.

Europe is also anticipated to register a noteworthy growth over the forecasted era given by the growing use of bioresorbable polymers in drug delivery and orthopedics applications. The Middle East & Africa, and Latin America are also anticipated to witness significant growth during the forecast period attributed to the rising consumer awareness and growth of healthcare industries.

Segmentation of Market covered in the research:

Bioresorbable Polymers Market Research Report: Information by Type (Agro-Polymers [Proteins and Polysaccharides] and Bio-polyesters [Polyglycolic Acid, Polylactic Acid, Polycaprolactone, Polydioxanone, and others]), Application (Orthopedics, Drug Delivery, and Others) and Region (Asia-Pacific, North America, Europe, Latin America, and Middle East & Africa) – Forecast till 2028


To Buy:
  https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=969


About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Contact:
Market Research Future

Phone:
+1 628 258 0071(US)  
+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.